Loading live market data…

Esperion Therapeutics, Inc.

NASDAQ:ESPR

$3.18 USD

$0 (0.0%)

Volume
59.09M
Average Volume
15.45M
Market Capitalization
$661.15M
P/E Ratio
-131.40
Dividend Yield
99.37%
Price Target
$3.16
Year High
$4.18
Year Low
$1.10
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.53

ESPR Estimated and Actual Revenue by Quarter

ESPR Estimated and Actual EPS by Quarter

ESPR Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 1 -75.61M -71.56M -73.8M -75.62M -71.57M -73.81M
2027-09-30 1 -71.03M -67.23M -69.33M -71.05M -67.24M -69.34M
2027-06-30 1 -66.75M -63.18M -65.15M -66.76M -63.19M -65.16M
2027-03-31 1 -60.89M -57.63M -59.43M -60.9M -57.64M -59.44M
2026-12-31 1 -62.25M -58.92M -60.76M -62.26M -58.93M -60.77M
2026-09-30 2 -58.17M -51.7M -55.65M -58.18M -51.71M -55.65M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 1 20.93M 22.48M 21.78M 150.56M 159.07M 155.26M
2027-09-30 1 16.1M 17.29M 16.76M 141.45M 149.45M 145.87M
2027-06-30 1 13.68M 14.7M 14.24M 132.92M 140.44M 137.07M
2027-03-31 1 8.05M 8.65M 8.38M 121.25M 128.1M 125.03M
2026-12-31 1 4.83M 5.19M 5.03M 123.97M 130.97M 127.84M
2026-09-30 2 -359.18K 897.96K 359.18K 108.77M 122.38M 117.07M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 1 126.94M 134.11M 130.9M 1 0.08325486 0.0894318 0.086667
2027-09-30 1 119.26M 126M 122.98M 1 0.06404228 0.06879377 0.066667
2027-06-30 1 112.07M 118.4M 115.57M 1 0.05443598 0.05847476 0.056667
2027-03-31 1 102.22M 108M 105.42M 1 0.03202066 0.03439637 0.033333
2026-12-31 1 104.52M 110.43M 107.78M 1 0.01921259 0.02063803 0.02
2026-09-30 2 91.71M 103.18M 98.71M 2 -0.001429 0.0035725 0.001429